Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk

International Journal of Medical Sciences

Volumn 9, Issue 6, 2012, Pages 498-508

  Zhi, Yi ^a   Yu, Jing ^a   Liu, Yang ^b   Wei, Quanfang ^a   Yuan, Fang ^a   Zhou, Xiaozhou ^a   Song, Bo ^a   Chen, Zhiwen ^a   Yang, Jin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Urology   (China)

Author keywords

Ataxia telangiectasia mutated; DNA repair; Multigenic variations; Mutl homolog 1; Polymorphism; Transitional cell carcinoma

Indexed keywords

ATM PROTEIN; NUCLEAR PROTEIN; PROTEIN MLH1; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XRCC1 PROTEIN; XRCC7 PROTEIN;

ADULT; ALLELE; ARTICLE; ATM GENE; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC STABILITY; GENETIC VARIABILITY; GENOTYPE; HMLH1 GENE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; XPC GENE; XRCC1 GENE; XRCC7 GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84866033751     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4799     Document Type: Article

References (32)

1. Verma S, Rajesh A, Prasad SR., et al. Urinary bladder cancer: role of MR imaging. Radiographics. 2012;32(2):371-387.
2. Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 2004;90 (11):2157-2166.
3. Bosetti C, Pira E, La Vecchia C. Bladder cancer risk in painters: a review of the epidemiological evidence, 1989-2004. Cancer Causes Control. 2005; 16(9):997-1008.
4. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001;291 (5507):1284-1289.
5. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006; 34 D617-D621.
6. Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 1998; 2 (2):223-232.
7. Min JH, Pavletich NP. Recognition of DNA damage by the Rad4 nucleotide excision repair protein. Nature 2007; 449 (7162):570-575.
8. Francisco G, Menezes PR, Eluf-Neto J, Chammas R. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet 2008;16 (6):724-734.
9. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. Embo J 1996;15 (23):6662-6670.
10. Wang Y, Yang H, Li H, Li L, Wang H, Liu C, Zheng Y. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett 2009;285 (2):134-140.
11. Ellison AR, Lofing J, Bitter GA. Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain. Nucleic Acids Res 2004;32 (18):5321-5338.
12. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27 (3):247-254.
13. Sipley JD, Menninger JC, Hartley KO, Ward DC, Jackson SP, Anderson CW. Gene for the catalytic subunit of the human DNA-activated protein kinase maps to the site of the XRCC7 gene on chromosome 8. Proc Natl Acad Sci U S A 1995;92 (16):7515-7519.
14. Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008;9 (10):759-769.
15. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3 (3):155-168.
16. Gonzalez-Hormazabal P, Bravo T, Blanco R, Valenzuela CY, Gomez F, Waugh E., et al. Association of common ATM variants with familial breast cancer in a South American population. BMC Cancer 2008;8:117.
17. Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M., et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003; 63 (24):8717-8725.
18. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer 2005;92 (12):2262-2265.
19. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. Comprehensive analysis of 22 XPC olymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15 (12):2537-541.
20. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U., et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004; 25 (5):729-734.
21. An Y, Jin G, Wang H, Wang Y, Liu H, Li R, et al. Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population. Lung Cancer 2008;59 (2):164-170.
22. Berndt SI, Platz EA, Fallin MD, Thuita LW, Hoffman SC, Helzlsouer KJ. Mismatch repair polymorphisms and the risk of colorectal cancer. Int J Cancer 2007;120 (7):1548-1554.
23. Fontana L, Bosviel R, Delort L, Guy L, Chalabi N, Kwiatkowski F., et al. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res 2008;28 (3B):1853-1856.
24. Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G., et al. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene 2006;25 (25):3613-3620.
25. Wang SY, Peng L, Li CP, Li AP, Zhou JW, Zhang ZD, Liu QZ. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer. Int J Urol 2008;15 (6):534-539.
26. Gangwar R, Mandhani A, Mittal RD. XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. J Cancer Res Clin Oncol 2010;136 (5):779-786.
27. Brown KL, Roginskaya M, Zou Y, Altamirano A, Basu AK, Stone MP. Binding of the human nucleotide excision repair proteins XPA and XPC/HR23B to the 5R-thymine glycol lesion and structure of the cis-(5R,6S) thymine glycol epimer in the 5'-GTgG-3' sequence: destabilization of two base pairs at the lesion site. Nucleic Acids Res 2010;38 (2):428-440.
28. Chen Z, Yang J, Wang G, Song B, Li J, Xu Z. Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res 2007;67 (10):4578-4585.
29. Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, Yuan JM., et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res 2009;69 (17):6857-6864.
30. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006;78 (3):464-479.
31. Raptis S, Mrkonjic M, Green RC, Pethe V V, Monga N, Chan YM., et al. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst 2007;99 (6):463-474.
32. Park SH, Lee GY, Jeon HS, Lee SJ, Kim KM., Jang SS, et al. -93G-->A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer 2004;112 (4):678-682.